Healthcare systems are constantly striving to balance two competing priorities—making essential medicines more affordable while fostering innovation for groundbreaking treatments. This intricate balancing act has grown increasingly complex in recent years, as escalating drug prices ignite debates on equity and access in healthcare. To tackle these challenges, the pharmaceutical industry leverages Health Economics and Outcomes Research (HEOR) as a powerful tool. HEOR provides data-backed insights that help streamline healthcare expenditures while keeping innovation within the reach of stakeholders. This blog explores how pharma heorhelps achieve the delicate equilibrium between drug affordability and pharmaceutical innovation in a rapidly expanding global healthcare...